Division of STD Prevention (EIS 2023)
Related Link
Goal:
The Division of STD Prevention aims to maximize the impact of sexually transmitted disease (STD) prevention through integrated programs, science, and policy to achieve healthy populations.
Objectives:
- Lead the response to and delay the emergence of multidrug-resistant (MDR) gonorrhea in the United States
- Develop evidence-based interventions to prevent congenital syphilis
- Modernize STD surveillance through informatics and new opportunities in emerging health information technologies
- Improve outbreak detection and response capacity
- Decrease the STD burden and highlight the need for an integrated approach to STD and human immunodeficiency virus (HIV) prevention among men who have sex with men (MSM)
- Decrease the STD burden and mitigate long-term health consequences associated with untreated STDs among sexually active youth and young adults
- Prevent STD-related adverse pregnancy outcomes
DSTDP Leadership, EIS Alumni, and Current EIS Officers
Leandro Mena, MD, MPH
Director
Raul A. Romaguera, DMD, MPH
Deputy Director
(EIS 1988)
Sevgi Aral, PhD, MA, MS
Chief Science Officer
Laura Bachmann, MD, MPH
Chief Medical Officer
Winston Abara, MD, PhD
(EIS 2015)
Bruce (“Bryce”) Furness, MD, MPH
(EIS 1998)
Eboni Galloway, PhD, MPH
(EIS 2010)
David Jackson, MD, MPH
(EIS 2017)
Felicia Lewis
(EIS 2004)
Lisa Llata, MD, MPH
(EIS 2007)
Robert McDonald MD, MPH
(EIS 2017)
Yasmin Ogale, PhD
(EIS 2021)
Laura Quilter, MD, MPH
(EIS 2017)
Julie Rushmore, PhD, DVM
(EIS 2019)
Lizzi Torrone, PhD, MSPH
(EIS 2009)
Sarah Wondmeneh, MD, MPH
(EIS 2022)
